Literature DB >> 20439097

Toward a more collaborative federal response to chronic kidney disease.

Andrew S Narva1, Michael Briggs, Regina Jordan, Meda E Pavkov, Nilka Rios Burrows, Desmond E Williams.   

Abstract

Chronic kidney disease (CKD) is a significant public health problem in the United States. However, data from the United States Renal Data System and other sources suggest that care for people with CKD does not meet recommended standards. The Federal government has developed the infrastructure to promote population-based interventions which have reduced the burden of other chronic illnesses. An effective, coordinated response by Federal health agencies to the public health challenge of CKD could have a significant effect on the morbidity, mortality, and costs associated with CKD. In recent years, initiatives undertaken by three Federal agencies have made important advances in coordinating efforts. The Centers for Disease Control and Prevention has begun to develop public health infrastructure for monitoring the burden of CKD. The Centers for Medicare and Medicaid Services has, through the successful Fistula First Breakthrough Initiative (FFBI) and inclusion of CKD in the scope of work of Quality Improvement Organizations, promoted earlier diagnosis and treatment of CKD. The National Institute of Diabetes and Digestive and Kidney Diseases, through its National Kidney Disease Education Program, has reinvigorated and expanded the Kidney Interagency Coordinating Committee so that it is a robust vehicle to share information about activities, identify and disseminate promising practices and tools, and foster cross-agency collaboration. Collaboration among Federal health agencies has the potential to enhance efforts to reduce the burden of CKD.

Entities:  

Mesh:

Year:  2010        PMID: 20439097      PMCID: PMC2875061          DOI: 10.1053/j.ackd.2010.03.006

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  9 in total

1.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Authors:  I Giatras; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

2.  Establishing a national chronic kidney disease surveillance system for the United States.

Authors:  Rajiv Saran; Elizabeth Hedgeman; Laura Plantinga; Nilka Rios Burrows; Brenda W Gillespie; Eric W Young; Josef Coresh; Meda Pavkov; Desmond Williams; Neil R Powe
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

3.  Late referral for dialysis: improving the management of chronic renal disease.

Authors:  P Roderick; C Jones; C Tomson; J Mason
Journal:  QJM       Date:  2002-06

4.  A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Authors:  Thomas J Hoerger; John S Wittenborn; Joel E Segel; Nilka R Burrows; Kumiko Imai; Paul Eggers; Meda E Pavkov; Regina Jordan; Susan M Hailpern; Anton C Schoolwerth; Desmond E Williams
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

5.  Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease.

Authors:  Lesley A Stevens; George Fares; James Fleming; David Martin; Kalyani Murthy; Jiejing Qiu; Paul C Stark; Katrin Uhlig; Frederick Van Lente; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

6.  The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Authors:  Mark J Sarnak; Tom Greene; Xuelei Wang; Gerald Beck; John W Kusek; Allan J Collins; Andrew S Levey
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

7.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Authors:  T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

8.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

  9 in total
  4 in total

1.  Study of Arteriovenous Fistula Cases in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

Authors:  Robin Man Karmacharya; Satish Vaidya; Amit Kumar Singh; Sushil Dahal; Prasesh Dhakal; Niroj Bhandari; Sohail Bade; Prabha Shrestha; Pratima Thapa
Journal:  JNMA J Nepal Med Assoc       Date:  2020-05-30       Impact factor: 0.406

2.  Prevalence and variation of Chronic Kidney Disease in the Irish health system: initial findings from the National Kidney Disease Surveillance Programme.

Authors:  Austin G Stack; Liam F Casserly; Cornelius J Cronin; Tetyana Chernenko; Walter Cullen; Ailish Hannigan; Rajiv Saran; Howard Johnson; Gemma Browne; John P Ferguson
Journal:  BMC Nephrol       Date:  2014-11-25       Impact factor: 2.388

3.  Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA.

Authors:  Brenda W Gillespie; Hal Morgenstern; Elizabeth Hedgeman; Anca Tilea; Natalie Scholz; Tempie Shearon; Nilka Rios Burrows; Vahakn B Shahinian; Jerry Yee; Laura Plantinga; Neil R Powe; William McClellan; Bruce Robinson; Desmond E Williams; Rajiv Saran
Journal:  Clin Kidney J       Date:  2015-11-03

4.  Health related quality of life among haemodialysis and kidney transplant recipients from Nepal: a cross sectional study using WHOQOL-BREF.

Authors:  Kamal Ranabhat; Pratik Khanal; Shiva Raj Mishra; Anu Khanal; Sangita Tripathi; Mahesh Raj Sigdel
Journal:  BMC Nephrol       Date:  2020-10-12       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.